This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Jyothsna Visweswaraiah, PhD
Director, Biotherapeutics Drug Creation at Seismic Therapeutic
Speaker

Profile

Jyothsna currently heads the biotherapeutics group at Seismic Therapeutic, where she and her team are applying machine learning insights to biologics drug discovery and development, to treat autoimmune diseases.


Agenda Sessions

  • Co-Chairs’ Remarks - Forward and Reverse Translation in Antibody Research

    2:25pm
  • Dual Cell Bidirectional Antibodies for Treating Autoimmunity

    11:00am